An Integrated Approach in Risk Management Process for Identifying Information Security Threats using Medical Research Design

In this paper, we attempt to introduce a new method for performing risk analysis studies by effectively adopting and adapting medical research design namely a prospective cohort study based survival analysis approach into risk management process framework. Under survival analysis approach, a method which is known as Cox Proportional Hazards (PH) Model will be applied in order to identify potential information security threats. The risk management process in this research will be based on Australian/New Zealand Standard for Risk Management (AS/NZS ISO 31000:2009). AS/NZS ISO 31000:2009 provides a sequencing of the core part of the risk management process namely establishing the context, risk identification, risk analysis, risk evaluation and risk treatment. Moreover, it seems that the integration of risk management process with medical approach indeed brings very useful new insights. Thus, the contribution of the paper will be introducing a new method for performing a risk analysis studies in information security domain

Privacy in the Genomic Era

Genome sequencing technology has advanced at a rapid pace and it is now possible to generate highly-detailed genotypes inexpensively. The collection and analysis of such data has the potential to support various applications, including personalized medical services. While the benefits of the genomics revolution are trumpeted by the biomedical community, the increased availability of such data has major implications for personal privacy; notably because the genome has certain essential features, which include (but are not limited to) (i) an association with traits and certain diseases, (ii) identification capability (e.g., forensics), and (iii) revelation of family relationships. Moreover, direct-to-consumer DNA testing increases the likelihood that genome data will be made available in less regulated environments, such as the Internet and for-profit companies. The problem of genome data privacy thus resides at the crossroads of computer science, medicine, and public policy. While the computer scientists have addressed data privacy for various data types, there has been less attention dedicated to genomic data. Thus, the goal of this paper is to provide a systematization of knowledge for the computer science community. In doing so, we address some of the (sometimes erroneous) beliefs of this field and we report on a survey we conducted about genome data privacy with biomedical specialists. Then, after characterizing the genome privacy problem, we review the state-of-the-art regarding privacy attacks on genomic data and strategies for mitigating such attacks, as well as contextualizing these attacks from the perspective of medicine and public policy. This paper concludes with an enumeration of the challenges for genome data privacy and presents a framework to systematize the analysis of threats and the design of countermeasures as the field moves forward

Human-Machine Collaborative Optimization via Apprenticeship Scheduling

Coordinating agents to complete a set of tasks with intercoupled temporal and resource constraints is computationally challenging, yet human domain experts can solve these difficult scheduling problems using paradigms learned through years of apprenticeship. A process for manually codifying this domain knowledge within a computational framework is necessary to scale beyond the ``single-expert, single-trainee" apprenticeship model. However, human domain experts often have difficulty describing their decision-making processes, causing the codification of this knowledge to become laborious. We propose a new approach for capturing domain-expert heuristics through a pairwise ranking formulation. Our approach is model-free and does not require enumerating or iterating through a large state space. We empirically demonstrate that this approach accurately learns multifaceted heuristics on a synthetic data set incorporating job-shop scheduling and vehicle routing problems, as well as on two real-world data sets consisting of demonstrations of experts solving a weapon-to-target assignment problem and a hospital resource allocation problem. We also demonstrate that policies learned from human scheduling demonstration via apprenticeship learning can substantially improve the efficiency of a branch-and-bound search for an optimal schedule. We employ this human-machine collaborative optimization technique on a variant of the weapon-to-target assignment problem. We demonstrate that this technique generates solutions substantially superior to those produced by human domain experts at a rate up to 9.5 times faster than an optimization approach and can be applied to optimally solve problems twice as complex as those solved by a human demonstrator.Comment: Portions of this paper were published in the Proceedings of the International Joint Conference on Artificial Intelligence (IJCAI) in 2016 and in the Proceedings of Robotics: Science and Systems (RSS) in 2016. The paper consists of 50 pages with 11 figures and 4 table

Artificial Intelligence in the Differential Diagnosis of Cardiomyopathy Phenotypes

Artificial intelligence (AI) is rapidly being applied to the medical field, especially in the cardiovascular domain. AI approaches have demonstrated their applicability in the detection, diagnosis, and management of several cardiovascular diseases, enhancing disease stratification and typing. Cardiomyopathies are a leading cause of heart failure and life-threatening ventricular arrhythmias. Identifying the etiologies is fundamental for the management and diagnostic pathway of these heart muscle diseases, requiring the integration of various data, including personal and family history, clinical examination, electrocardiography, and laboratory investigations, as well as multimodality imaging, making the clinical diagnosis challenging. In this scenario, AI has demonstrated its capability to capture subtle connections from a multitude of multiparametric datasets, enabling the discovery of hidden relationships in data and handling more complex tasks than traditional methods. This review aims to present a comprehensive overview of the main concepts related to AI and its subset. Additionally, we review the existing literature on AI-based models in the differential diagnosis of cardiomyopathy phenotypes, and we finally examine the advantages and limitations of these AI approaches

Systematizing Genome Privacy Research: A Privacy-Enhancing Technologies Perspective

Rapid advances in human genomics are enabling researchers to gain a better understanding of the role of the genome in our health and well-being, stimulating hope for more effective and cost efficient healthcare. However, this also prompts a number of security and privacy concerns stemming from the distinctive characteristics of genomic data. To address them, a new research community has emerged and produced a large number of publications and initiatives. In this paper, we rely on a structured methodology to contextualize and provide a critical analysis of the current knowledge on privacy-enhancing technologies used for testing, storing, and sharing genomic data, using a representative sample of the work published in the past decade. We identify and discuss limitations, technical challenges, and issues faced by the community, focusing in particular on those that are inherently tied to the nature of the problem and are harder for the community alone to address. Finally, we report on the importance and difficulty of the identified challenges based on an online survey of genome data privacy expertsComment: To appear in the Proceedings on Privacy Enhancing Technologies (PoPETs), Vol. 2019, Issue

Contemporary Clinical and Molecular Epidemiology of Vancomycin-Resistant Enterococcal Bacteremia: A Prospective Multicenter Cohort Study (VENOUS I)

Background Vancomycin-resistant enterococci (VRE) are major therapeutic challenges. Prospective contemporary data characterizing the clinical and molecular epidemiology of VRE bloodstream infections (BSIs) are lacking. Methods The Vancomycin-Resistant Enterococcal BSI Outcomes Study (VENOUS I) is a prospective observational cohort of adult patients with enterococcal BSI in 11 US hospitals. We included patients with Enterococcus faecalis or Enterococcus faecium BSI with >= 1 follow-up blood culture(s) within 7 days and availability of isolate(s) for further characterization. The primary study outcome was in-hospital mortality. Secondary outcomes were mortality at days 4, 7, 10, 12, and 15 after index blood culture. A desirability of outcome ranking was constructed to assess the association of vancomycin resistance with outcomes. All index isolates were subjected to whole genome sequencing. Results Forty-two of 232 (18%) patients died in hospital and 39 (17%) exhibited microbiological failure (lack of clearance in the first 4 days). Neutropenia (hazard ratio [HR], 3.13), microbiological failure (HR, 2.4), VRE BSI (HR, 2.13), use of urinary catheter (HR, 1.85), and Pitt BSI score >= 2 (HR, 1.83) were significant predictors of in-hospital mortality. Microbiological failure was the strongest predictor of in-hospital mortality in patients with E faecium bacteremia (HR, 5.03). The impact of vancomycin resistance on mortality in our cohort changed throughout the course of hospitalization. Enterococcus faecalis sequence type 6 was a predominant multidrug-resistant lineage, whereas a heterogeneous genomic population of E faecium was identified. Conclusions Failure of early eradication of VRE from the bloodstream is a major factor associated with poor outcomes. Failure to eradicate enterococci from the bloodstream in the first 4 days after the index blood culture was the most consistent factor associated with increased risk of mortality. The association of vancomycin resistance with mortality changed throughout the course of the hospitalization

Effective and Secure Healthcare Machine Learning System with Explanations Based on High Quality Crowdsourcing Data

Affordable cloud computing technologies allow users to efficiently outsource, store, and manage their Personal Health Records (PHRs) and share with their caregivers or physicians. With this exponential growth of the stored large scale clinical data and the growing need for personalized care, researchers are keen on developing data mining methodologies to learn efficient hidden patterns in such data. While studies have shown that those progresses can significantly improve the performance of various healthcare applications for clinical decision making and personalized medicine, the collected medical datasets are highly ambiguous and noisy. Thus, it is essential to develop a better tool for disease progression and survival rate predictions, where dataset needs to be cleaned before it is used for predictions and useful feature selection techniques need to be employed before prediction models can be constructed. In addition, having predictions without explanations prevent medical personnel and patients from adopting such healthcare deep learning models. Thus, any prediction models must come with some explanations. Finally, despite the efficiency of machine learning systems and their outstanding prediction performance, it is still a risk to reuse pre-trained models since most machine learning modules that are contributed and maintained by third parties lack proper checking to ensure that they are robust to various adversarial attacks. We need to design mechanisms for detection such attacks. In this thesis, we focus on addressing all the above issues: (i) Privacy Preserving Disease Treatment & Complication Prediction System (PDTCPS): A privacy-preserving disease treatment, complication prediction scheme (PDTCPS) is proposed, which allows authorized users to conduct searches for disease diagnosis, personalized treatments, and prediction of potential complications. (ii) Incentivizing High Quality Crowdsourcing Data For Disease Prediction: A new incentive model with individual rationality and platform profitability features is developed to encourage different hospitals to share high quality data so that better prediction models can be constructed. We also explore how data cleaning and feature selection techniques affect the performance of the prediction models. (iii) Explainable Deep Learning Based Medical Diagnostic System: A deep learning based medical diagnosis system (DL-MDS) is present which integrates heterogeneous medical data sources to produce better disease diagnosis with explanations for authorized users who submit their personalized health related queries. (iv) Attacks on RNN based Healthcare Learning Systems and Their Detection & Defense Mechanisms: Potential attacks on Recurrent Neural Network (RNN) based ML systems are identified and low-cost detection & defense schemes are designed to prevent such adversarial attacks. Finally, we conduct extensive experiments using both synthetic and real-world datasets to validate the feasibility and practicality of our proposed systems